349 related articles for article (PubMed ID: 12116254)
1. Complete SHOX deficiency causes Langer mesomelic dysplasia.
Zinn AR; Wei F; Zhang L; Elder FF; Scott CI; Marttila P; Ross JL
Am J Med Genet; 2002 Jun; 110(2):158-63. PubMed ID: 12116254
[TBL] [Abstract][Full Text] [Related]
2. Pseudodominant inheritance of Langer mesomelic dysplasia caused by a SHOX homeobox missense mutation.
Shears DJ; Guillen-Navarro E; Sempere-Miralles M; Domingo-Jimenez R; Scambler PJ; Winter RM
Am J Med Genet; 2002 Jun; 110(2):153-7. PubMed ID: 12116253
[TBL] [Abstract][Full Text] [Related]
3. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome).
Belin V; Cusin V; Viot G; Girlich D; Toutain A; Moncla A; Vekemans M; Le Merrer M; Munnich A; Cormier-Daire V
Nat Genet; 1998 May; 19(1):67-9. PubMed ID: 9590292
[TBL] [Abstract][Full Text] [Related]
4. Impairment of SHOX nuclear localization as a cause for Léri-Weill syndrome.
Sabherwal N; Schneider KU; Blaschke RJ; Marchini A; Rappold G
J Cell Sci; 2004 Jun; 117(Pt 14):3041-8. PubMed ID: 15173321
[TBL] [Abstract][Full Text] [Related]
5. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis.
Shears DJ; Vassal HJ; Goodman FR; Palmer RW; Reardon W; Superti-Furga A; Scambler PJ; Winter RM
Nat Genet; 1998 May; 19(1):70-3. PubMed ID: 9590293
[TBL] [Abstract][Full Text] [Related]
6. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.
Jorge AA; Souza SC; Nishi MY; Billerbeck AE; Libório DC; Kim CA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2007 Jan; 66(1):130-5. PubMed ID: 17201812
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of SHOX deficiency.
Nicolosi A; Caruso-Nicoletti M
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):7-10. PubMed ID: 21057178
[TBL] [Abstract][Full Text] [Related]
8. Analysis of short stature homeobox-containing gene ( SHOX) and auxological phenotype in dyschondrosteosis and isolated Madelung deformity.
Grigelioniene G; Schoumans J; Neumeyer L; Ivarsson A; Eklöf O; Enkvist O; Tordai P; Fosdal I; Myhre AG; Westphal O; Nilsson NO; Elfving M; Ellis I; Anderlid BM; Fransson I; Tapia-Paez I; Nordenskjöld M; Hagenäs L; Dumanski JP
Hum Genet; 2001 Nov; 109(5):551-8. PubMed ID: 11735031
[TBL] [Abstract][Full Text] [Related]
9. FGFR3 is a target of the homeobox transcription factor SHOX in limb development.
Decker E; Durand C; Bender S; Rödelsperger C; Glaser A; Hecht J; Schneider KU; Rappold G
Hum Mol Genet; 2011 Apr; 20(8):1524-35. PubMed ID: 21273290
[TBL] [Abstract][Full Text] [Related]
10. A170P mutation in SHOX gene in a patient not presenting with Madelung deformity.
Alvarez-Mora MI; Madrigal I; Rodriguez-Revenga L; Mur A; Calvo D; Pascual I Bardají J; Milà M
J Clin Pathol; 2012 Sep; 65(9):844-6. PubMed ID: 22461651
[TBL] [Abstract][Full Text] [Related]
11. PAR1 deletions downstream of SHOX are the most frequent defect in a Spanish cohort of Léri-Weill dyschondrosteosis (LWD) probands.
Benito-Sanz S; del Blanco DG; Aza-Carmona M; Magano LF; Lapunzina P; Argente J; Campos-Barros A; Heath KE
Hum Mutat; 2006 Oct; 27(10):1062. PubMed ID: 16941489
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency.
Iughetti L; Madeo S; Predieri B
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):34-8. PubMed ID: 21057184
[TBL] [Abstract][Full Text] [Related]
13. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
[TBL] [Abstract][Full Text] [Related]
14. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Xpter encompassing the SHOX gene and PAR1 region in familial patients with Leri-Weill Dyschondrosteosis syndrome.
Mutesa L; Vanbellinghen JF; Hellin AC; Segers K; Jamar M; Pierquin G; Bours V
Genet Couns; 2009; 20(1):9-17. PubMed ID: 19400538
[TBL] [Abstract][Full Text] [Related]
16. The SHOX region and its mutations.
Capone L; Iughetti L; Sabatini S; Bacciaglia A; Forabosco A
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):11-4. PubMed ID: 21057179
[TBL] [Abstract][Full Text] [Related]
17. [From gene to disease; from SHOX to Lèri-Weill dyschondrosteosis, Turner syndrome and idiopathic short stature].
Kant SG; Drop SL
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1456-9. PubMed ID: 11503314
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular characterization of Chilean patients with Léri-Weill dyschondrosteosis.
Rodríguez FA; Unanue N; Hernandez MI; Basaure J; Heath KE; Cassorla F
J Pediatr Endocrinol Metab; 2013; 26(7-8):729-34. PubMed ID: 23729538
[TBL] [Abstract][Full Text] [Related]
19. Mosaic compound heterozygosity of SHOX resulting in Leri-Weill dyschondrosteosis with marked short stature: implications for disease mechanisms and recurrence risks.
Reish O; Huber C; Altarescu G; Chapman-Shimshoni D; Levy-Lahad E; Renbaum P; Mashevich M; Munnich A; Cormier-Daire V
Am J Med Genet A; 2010 Sep; 152A(9):2230-5. PubMed ID: 20683993
[TBL] [Abstract][Full Text] [Related]
20. Langer mesomelic dysplasia in early fetuses: two cases and a literature review.
Ambrosetti F; Palicelli A; Bulfamante G; Rivasi F
Fetal Pediatr Pathol; 2014 Apr; 33(2):71-83. PubMed ID: 23883335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
